Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
170M
-
Number of holders
-
168
-
Total 13F shares, excl. options
-
96.2M
-
Shares change
-
+1.94M
-
Total reported value, excl. options
-
$1.54B
-
Value change
-
+$26M
-
Put/Call ratio
-
1.2
-
Number of buys
-
95
-
Number of sells
-
-96
-
Price
-
$16.00
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q2 2025
236 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 96.2M shares
of 170M outstanding shares and own 56.65% of the company stock.
Largest 10 shareholders include FMR LLC (18.6M shares), Deep Track Capital, LP (9.5M shares), VANGUARD GROUP INC (7.03M shares), T. Rowe Price Investment Management, Inc. (6.88M shares), BlackRock, Inc. (5.85M shares), BAKER BROS. ADVISORS LP (5.46M shares), ARMISTICE CAPITAL, LLC (5.2M shares), Point72 Asset Management, L.P. (3.34M shares), STATE STREET CORP (2.83M shares), and Alpine Global Management, LLC (2.63M shares).
This table shows the top 168 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.